Associate Professor, Obstetrics and Gynecology, UCLA School of Medicine Director of Gynecologic Oncology Fellowship at UCLA/Cedars-Sinai Medical Center
Obstetrics & Gynecology
Dr. Christine S. Walsh, MD
|
|
Give Review
Christine Walsh practices Obstetrics & Gynecology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. He received 1 awards: "Fellow (FACOG)". Christine S. Walsh, MD is also a published doctor. He has 30 publication published. The most recent publication is: Leveraging DNA repair deficiency in gynecologic oncology. He is registered with Medicare.
Publications
- Digoxin therapy is not associated with improved survival in epithelial ovarian Cancer: A SEER-Medicare database analysis.
- Leveraging DNA repair deficiency in gynecologic oncology.
- Common variants at the CHEK2 gene locus and risk of epithelial ovarian Cancer.
- Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.
- Evaluating the ovarian Cancer gonadotropin hypothesis: A candidate gene study.
- Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers.
- ABCA transporter gene expression and poor outcome in epithelial ovarian Cancer.
- Risk Factors for Recurrence and Prognosis of Low-grade Endometrial AdenoCarcinoma; Vaginal Versus Other Sites.
- Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian Cancer outcome.
- Thrombocytosis at secondary cytoreduction for recurrent ovarian Cancer predicts suboptimal resection and poor survival.
- POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian Cancer.
- Post Treatment Surveillance of Type II Endometrial Cancer Patients.
- Venous thromboembolism during primary treatment of ovarian clear cell Carcinoma is associated with decreased survival.
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
- Predictors of invasive adenoCarcinoma after conization for cervical adenoCarcinoma in situ.
- Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenoCarcinoma in premenopausal women treated with progestin therapy.
- Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survi...
- CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian Cancer.
- Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenoCarcinoma?
- Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
- Lymphadenectomy's role in early endometrial Cancer: prognostic or therapeutic?
- Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian Carcinomas.
- ERCC5 is a novel biomarker of ovarian Cancer prognosis.
- Fertility-sparing surgery in 101 women with adenoCarcinoma in situ of the cervix.
- Contemporary progress in ovarian Cancer screening.
- Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial Cancer risk.
- The prognostic significance of thrombocytosis in uterine papillary serous Carcinomas.
- Discovery of epigenetically masked tumor suppressor genes in endometrial Cancer.
Schools
Columbia University College of Physicians And Surgeons
Procedures Preformed
- Colposcopy
- Destruction or Excision of Vaginal Lesions
- Endocervical Curettage
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Access Plus Savenet
- Basic PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Optima Health
- POMCO Group
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- Fellow (FACOG)
Education
-
Brigham and Women's Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1083666721 | |
| NPPES Provider LastName | WALSH | |
| NPPES Provider FirstName | CHRISTINE | |
| NPPES Provider ZIPCode | 900481804 | |
| NPPES Provider State | CA | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083666721 |
| Last Name Of The Provider | WALSH |
| First Name Of The Provider | CHRISTINE |
| View All |
Similar Doctors
|
|
Dr. Pamela R. Fenton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mae M. Ushigome, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica L. Schneider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth Y. Karlan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ilana Cass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara J. Churchill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane L. Davis, MD
This Doctor is OpenDoctor Recommended.
|